Publications by authors named "Raquel Gasque Rubio"

Claim this Profile
C
Cross-platform analytical assessment of serum GFAP quantification in multiple sclerosis: SIMOA versus two automated immunoassays.
Jordi Tortosa-Carreres, Laura Cubas-Núñez, Jéssica Castillo-Villalba, Lorena Forés-Toribio, Raquel Gasque-Rubio

Front Neurol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamic 18 F-FDG PET to detect differences among patients with progressive and relapsing multiple sclerosis: a pilot study.
Carlos Quintanilla-Bordás, Matías Fernández-Patón, Amadeo Ten, Cristina Ferrer-Pardo, Sara Carratala-Bosca, Raquel Gasqué-Rubio

Neurol Sci· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Dynamic 18 F-FDG PET to detect differences among patients with progressive and relapsing multiple sclerosis: a pilot study.
Carlos Quintanilla-Bordás, Matías Fernández-Patón, Amadeo Ten, Cristina Ferrer-Pardo, Sara Carratala-Bosca, Raquel Gasqué-Rubio

Neurol Sci· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Renal function's impact on serum neurofilament levels in patients with multiple sclerosis: an exploratory analysis.
Jordi Tortosa-Carreres, Laura Cubas-Núñez, Maria Teresa Sanz, Jessica Castillo-Villalba, Raquel Gasqué-Rubio

Neurol Sci· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical trajectories of patients with multiple sclerosis from onset and their relationship with serum neurofilament light chain levels.
Carlos Quintanilla-Bordás, Laura Cubas-Núñez, Jéssica Castillo-Villalba, Sara Carratalá-Boscá, Raquel Gasque-Rubio

Front Neurol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the complement C1q levels in serum and cerebrospinal fluid in multiple sclerosis patients: Could it serve as a valuable marker in clinical practice?
Jordi Tortosa-Carreres, Laura Cubas-Núñez, Mónica Piqueras, Jéssica Castillo-Villalba, Carlos Quintanilla-Bordàs, Raquel Gasque-Rubio

J Neuroimmunol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive potential of serum and cerebrospinal fluid biomarkers for disease activity in treated multiple sclerosis patients.
Jordi Tortosa-Carreres, Laura Cubas-Núñez, Ana Quiroga-Varela, Jessica Castillo-Villalba, Lluís Ramió-Torrenta, Raquel Gasqué-Rubio

Mult Scler Relat Disord· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving the efficiency of free kappa light chains as diagnostic biomarker of Multiple Sclerosis by using a novel algorithm.
Jordi Tortosa-Carreres, Anna Quiroga-Varela, Jessica Castillo-Villalba, Mónica Piqueras-Rodríguez, Lluís Ramió-Torrenta, Raquel Gasqué-Rubio

Mult Scler Relat Disord· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is it cost-effective to request IgM oligoclonal bands against lipids in daily practice as a biomarker for poor prognosis in multiple sclerosis?
Sara Ribes García, Jessica Castillo-Villalba, Raquel Gasque Rubio, Sara Carratalà Boscà, Laura Cubas-Nuñez

Mult Scler Relat Disord· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oligoclonal M bands and cervical spinal cord lesions predict early secondary progressive multiple sclerosis.
Carmen Alcalá Vicente, Laura Lacruz, Francisco Gascón, Sara Carratalà, Carlos Quintanilla-Bordás, Raquel Gasqué Rubio

Front Neurol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High Levels of Cerebrospinal Fluid Kappa Free Light Chains Relate to IgM Intrathecal Synthesis and Might Have Prognostic Implications in Relapsing Multiple Sclerosis.
Jéssica Castillo-Villalba, Sara Gil-Perotín, Raquel Gasque-Rubio, Laura Cubas-Nuñez, Sara Carratalà-Boscà

Front Immunol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case Report: Exacerbation of Relapses Following mRNA COVID-19 Vaccination in Multiple Sclerosis: A Case Series.
Carlos Quintanilla-Bordás, Francisco Gascón-Gimenez, Carmen Alcalá, María Payá, Javier Mallada, Raquel Gasque-Rubio

Front Neurol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epilepsy, status epilepticus, and hemiplegic migraine coexisting with a novel SLC4A4 mutation.
Sara Gil-Perotín, Teresa Jaijo, Andrés G Verdú, Pilar Rubio, Miguel Mazón, Raquel Gasqué-Rubio

Neurol Sci· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential Role of CHI3L1+ Astrocytes in Progression in MS.
Laura Cubas-Núñez, Sara Gil-Perotín, Jéssica Castillo-Villalba, Verónica López, Luis Solís Tarazona, Raquel Gasqué-Rubio

Neurol Neuroimmunol Neuroinflamm· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis